Disclosed a system (100) for enacting a positive and a negative pressure on a limb. The system (100) includes an air compressor (102) coupled to a reservoir (104), a piston assembly (106) configured to the reservoir (104), wherein the piston assembly (106) further comprises a piston (108) circumfused inside a tube (107), a pneumatic ring (114) coupled to the system (100) via the piston assembly (106) maintains intermittent pressure and prevents formation of a venous blood clot ischemic injury to a tissue distal to the pneumatic ring (114) compression due to lack of blood flow.

A method of treatment for congestive colon failure (CCF) including evaluating an origin of a lipase and/or an amylase from a biological fluid sample from the subject, optionally analyzing a level of the lipase and/or an amylase from the biological fluid sample from the subject, optionally imaging a colon and a pancreas of the subject and providing laxatives, an anti-fungal composition, fat, a composition selected from a group comprising glucosamine, methylsulfonylmethane (MSM) rhamnan sulfate, Sulodexide, Rosuvastatin, Metformin, Hydrocortisone, Antithrombin, Etanercept, Heparin, Albumin, Fresh frozen plasma (FFP), Poloxamer-188, vitamins, trace elements, a locally acting vasodilator, anaerobic microbial culture, pickled fruits, pickled vegetables, preserved meat, and fermented juices or a combination thereof based upon results of the first three steps.

A sample container system for use in a method for determining dietary fiber comprises a sample container and a magnetic mixer. The sample container has a floor and a rigid side-wall upstanding therefrom to together delimit a sample containing space, wherein the floor includes a porous filter portion. The magnetic mixer has at least one concentrically arranged rotor-stator, each of the at least one concentrically arranged rotor-stator including a rotor and a stator, the rotor and the stator defining therebetween an annular shear gap, the rotor configured to rotate relative to the stator, the stator including a stator body having a first plurality of openings therethrough, the rotor including a magnetic coupling and a rotor body having a second plurality of openings therethrough, the magnetic coupling configured to couple with and follow an externally generated rotating magnetic field to cause the rotor to rotate in relation to the stator.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

The present disclosure relates to an organism trapping device that includes a vibration wave generator configured to generate frequency ranges from 1.00 to 1.67 Hz (Hertz), an inciting engine communicatively coupled with the vibration wave generator, and configured to generate signals representing vibration parameters based on the generated frequency, a walled container operatively coupled with the inciting engine and adapted to contain fluid and receives the generated signals to simulate flow of blood in human blood vessels based on the vibration parameters to attract number of organisms towards the device, a fumigating agent adapted to compress the number of organisms entering into the device, sensors configured to sense an entry of number of organisms into the device, and a processor communicatively coupled with the sensor and activates the fumigating agent based on the signal received from the sensor. The present disclosure also relates to method of trapping organisms.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.